Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-center, Single-arm Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Male and Female Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU)

NCT05526521 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT05526521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05526521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-center, Single-arm Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Male and Female Participants ≥2 Years to <12 Years of Age With Uncontrolled Chronic Spontaneous Urticaria (CSU)
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
August 25, 2022
Completion date
February 3, 2025
Enrollment
15 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

chronic spontaneous urticaria